Medpace Holdings (MEDP) Other Accumulated Expenses (2015 - 2026)

Medpace Holdings has reported Other Accumulated Expenses for 12 years, with the latest figure at $48.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 14.23% year-over-year to $48.2 million; the trailing twelve-month figure through Mar 2026 stood at $48.2 million (down 14.23% YoY), and the FY2025 full-year result was $52.8 million, down 1.49% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $48.2 million, down from $52.8 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $62.5 million in Q1 2023, with the low at $25.9 million in Q2 2022.
• Historically, Other Accumulated Expenses has averaged $43.7 million across 5 years, with a median of $44.6 million in 2024.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 270.97% — and 2024, when it decreased 28.65%.
• Medpace Holdings' Other Accumulated Expenses stood at $47.5 million in 2022, then slipped by 14.95% to $40.4 million in 2023, then surged by 32.62% to $53.6 million in 2024, then retreated by 1.49% to $52.8 million in 2025, then decreased by 8.8% to $48.2 million in 2026.
• The last three Other Accumulated Expenses figures came in at $48.2 million (Q1 2026), $52.8 million (Q4 2025), and $54.3 million (Q3 2025), per Business Quant data.